![]() |
|
|
Vol. 28, Issue 2, 103-106, February 2000
The optimization of pharmacokinetic properties remains one of the
most challenging aspects of drug design. Key parameters, clearance and
volume of distribution, are multifactorial, which makes deriving
structure-pharmacokinetic relationships difficult. The correction of
clearance and volume of distribution for the unbound fraction in plasma
is one approach taken that has enabled quantitative
structure-pharmacokinetic relationships to be derived. Three published
data-sets where unbound parameters have been correlated with
lipophilicity have been reanalyzed. The reanalysis has shown that high
correlation coefficients can be achieved without any true correlation
in the data and can lead to misinterpretation of the ways in which
lipophilicity influences pharmacokinetics. Randomization procedures are
proposed as a more robust method of assessing significance.